APOA4 抗体 (AA 21-396)
Quick Overview for APOA4 抗体 (AA 21-396) (ABIN968958)
抗原
See all APOA4 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 21-396
-
原理
- APOA4 Antibody
-
纯化方法
- Ascitic fluid
-
免疫原
- Purified recombinant fragment of APOA4 (aa21-396) expressed in E. Coli.
-
亚型
- IgG2a
-
-
-
-
应用备注
- ELISA: 1/10000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Ascitic fluid containing 0.03 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
-
: "Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population." in: Clinica chimica acta; international journal of clinical chemistry, Vol. 388, Issue 1-2, pp. 78-83, (2007) (PubMed).
: "E-cadherin-dependent transcriptional control of apolipoprotein A-IV gene expression in intestinal epithelial cells: a role for the hepatic nuclear factor 4." in: The Journal of biological chemistry, Vol. 281, Issue 6, pp. 3560-8, (2006) (PubMed).
-
: "Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population." in: Clinica chimica acta; international journal of clinical chemistry, Vol. 388, Issue 1-2, pp. 78-83, (2007) (PubMed).
-
- APOA4 (Apolipoprotein A-IV (APOA4))
-
别名
- APOA4
-
背景
- APOA4: apolipoprotein A-IV. Apoliprotein (apo) A-IV gene contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon. The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles. Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro.
-
分子量
- 45 kDa
-
基因ID
- 337
-
UniProt
- P06727
-
途径
- Lipid Metabolism
抗原
-